Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro.
about
Biosynthesis of promatrix metalloproteinase-9/chondroitin sulphate proteoglycan heteromer involves a Rottlerin-sensitive pathwayNetwork based elucidation of drug response: from modulators to targets.Discovery and Characterization of a Biologically Active Non-ATP-Competitive p38 MAP Kinase Inhibitor.Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRafIL-1β-induced and p38MAPK-dependent activation of the mitogen-activated protein kinase-activated protein kinase 2 (MK2) in hepatocytes: Signal transduction with robust and concentration-independent signal amplification.Novel Noncatalytic Substrate-Selective p38α-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity.
P2860
Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@ast
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@en
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@nl
type
label
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@ast
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@en
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@nl
prefLabel
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@ast
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@en
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Two additive mechanisms impair ...... sical p38 inhibitors in vitro.
@en
P2093
Bart S Hendriks
Jeffrey R Chabot
Kelly M Seidl
P2860
P2888
P356
10.1186/1752-0509-4-23
P577
2010-03-15T00:00:00Z
P5875
P6179
1020015574